Evidence map›Paper›PMID 16481629›Full record

ArticleGut2006

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

S P L Travis, E F Stange, M Lémann, T Oresland, Y Chowers, A Forbes, G D'Haens, G Kitis, A Cortot, C Prantera and 9 more

3 registry-linked trialsOpen access · bronzeAbstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Gut, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 158 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
158citing papers in PubMed, 13 pooled it
43.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00305409 nacompletednot on this map

Synbiotic Treatment in Crohn's Disease Patients

TypeinterventionalSponsorUniversity of DundeeRan2006 to 2008Enrolled50ConditionsCrohn's DiseaseArmsSynbiotic (Synergy I / B.longum)
NCT01015391 naunknown statusnot on this mapstarted 2009, after this paper: background citation

A Randomized, Controlled, Open-label Study to Assess the Efficacy of T2 Versus Azathioprine for the Maintenance of Clinical and Endoscopic Remission in Subjects With Crohn's Disease After Surgical Resection

TypeinterventionalSponsorJinling Hospital, ChinaRan2009 to 2013Enrolled100ConditionsCrohn's DiseaseArmsT2, Azathioprine
NCT02624037 nacompletednot on this mapstarted 2015, after this paper: background citation

Precision IFX: Using a Pharmacokinetic Dashboard to Optimize and Individualize Infliximab Dosage for Pediatric Inflammatory Bowel Disease Patients

TypeinterventionalSponsorIcahn School of Medicine at Mount SinaiRan2015 to 2020Enrolled189ConditionsInflammatory Bowel DiseaseArmsIndividualized Dosage Precision IFX Dashboard
3 · Its place in the literature

Who cites it

158 citing papers in PubMed, 13 syntheses or guidelines pooled it, 603 citations in OpenAlex.

  1. Pooled it
  2. ACG Clinical Guideline: Management of Crohn's Disease in Adults.The American journal of gastroenterology · 2018
    Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Guideline
  7. Inflammatory bowel disease in India--changing paradigms.International journal of colorectal disease · 2011
    Pooled it
  8. Crohn's disease.BMJ clinical evidence · 2011
    Pooled it
  9. Laparoscopic versus Open surgery for small bowel Crohn's disease.The Cochrane database of systematic reviews · 2011
    Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Crohn's disease.BMJ clinical evidence · 2007
    Pooled it
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Review
  20. Article

98 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 1 institution in 1 country.

S P L TravisJohn Radcliffe Hospital, Oxford OX3 9DU, UK. simon.travis@orh.nhs.uk
E F Stange
M Lémann
T Oresland
Y Chowers
A Forbes
G D'Haens
G Kitis
A Cortot
C Prantera
P Marteau
J-F Colombel
P Gionchetti
Y Bouhnik
E Tiret
J Kroesen
M Starlinger
N J Mortensen
European Crohn's and Colitis Organisation
John Radcliffe Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This second section of the European Crohn's and Colitis Organisation (ECCO) Consensus on the management of Crohn's disease concerns treatment of active disease, maintenance of medically induced remission, and surgery. The first section on definitions and diagnosis includes the aims and methods of the consensus, as well as sections on diagnosis, pathology, and classification of Crohn's disease. The third section on special situations in Crohn's disease includes postoperative recurrence, fistulating disease, paediatrics, pregnancy, psychosomatics, extraintestinal manifestations, and alternative therapy for Crohn's disease.

Indexed as

Adrenal Cortex HormonesAminosalicylic AcidsAnti-Bacterial AgentsAntibodies, MonoclonalClinical Trials as TopicCrohn DiseaseDrug ResistanceEvidence-Based MedicineGastrointestinal AgentsHumansImmunosuppressive AgentsInfliximabMethotrexatePatient SelectionPurinesRemission InductionAdrenal Cortex HormonesAminosalicylic AcidsAnti-Bacterial AgentsAntibodies, MonoclonalGastrointestinal AgentsImmunosuppressive AgentsInfliximabMethotrexatePurines

Identifiers

PMID16481629
PMCPMC1859997
OpenAlexW2104784902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.